nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—Surgical intervention—Nevirapine—acquired immunodeficiency syndrome	0.0519	0.0786	CcSEcCtD
Molindone—Surgery—Nevirapine—acquired immunodeficiency syndrome	0.0519	0.0786	CcSEcCtD
Molindone—Pigmentation skin—Zidovudine—acquired immunodeficiency syndrome	0.05	0.0757	CcSEcCtD
Molindone—Pigmentation disorder—Zidovudine—acquired immunodeficiency syndrome	0.0274	0.0414	CcSEcCtD
Molindone—HTR7—nerve—acquired immunodeficiency syndrome	0.0155	0.0707	CbGeAlD
Molindone—DRD2—nerve—acquired immunodeficiency syndrome	0.0147	0.0668	CbGeAlD
Molindone—HTR7—endothelium—acquired immunodeficiency syndrome	0.0132	0.0602	CbGeAlD
Molindone—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.0123	0.0559	CbGeAlD
Molindone—HTR7—blood plasma—acquired immunodeficiency syndrome	0.0117	0.0534	CbGeAlD
Molindone—HTR2A—nerve—acquired immunodeficiency syndrome	0.00967	0.0441	CbGeAlD
Molindone—Gynaecomastia—Stavudine—acquired immunodeficiency syndrome	0.0094	0.0142	CcSEcCtD
Molindone—Hyperkinesia—Nelfinavir—acquired immunodeficiency syndrome	0.00919	0.0139	CcSEcCtD
Molindone—Amenorrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00874	0.0132	CcSEcCtD
Molindone—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.0086	0.0392	CbGeAlD
Molindone—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00823	0.0375	CbGeAlD
Molindone—Gynaecomastia—Zidovudine—acquired immunodeficiency syndrome	0.00817	0.0124	CcSEcCtD
Molindone—Salivary hypersecretion—Delavirdine—acquired immunodeficiency syndrome	0.00746	0.0113	CcSEcCtD
Molindone—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.00731	0.0333	CbGeAlD
Molindone—Gynaecomastia—Efavirenz—acquired immunodeficiency syndrome	0.00718	0.0109	CcSEcCtD
Molindone—Euphoric mood—Efavirenz—acquired immunodeficiency syndrome	0.0069	0.0104	CcSEcCtD
Molindone—Euphoric mood—Delavirdine—acquired immunodeficiency syndrome	0.0066	0.00998	CcSEcCtD
Molindone—Hyperkinesia—Ritonavir—acquired immunodeficiency syndrome	0.00619	0.00937	CcSEcCtD
Molindone—Euphoric mood—Ritonavir—acquired immunodeficiency syndrome	0.0061	0.00923	CcSEcCtD
Molindone—DRD2—retina—acquired immunodeficiency syndrome	0.00607	0.0277	CbGeAlD
Molindone—Weight decreased—Stavudine—acquired immunodeficiency syndrome	0.00596	0.00902	CcSEcCtD
Molindone—Euphoric mood—Saquinavir—acquired immunodeficiency syndrome	0.00587	0.00888	CcSEcCtD
Molindone—Gynaecomastia—Lamivudine—acquired immunodeficiency syndrome	0.00583	0.00883	CcSEcCtD
Molindone—Dysphagia—Zidovudine—acquired immunodeficiency syndrome	0.00573	0.00867	CcSEcCtD
Molindone—Disturbance in sexual arousal—Delavirdine—acquired immunodeficiency syndrome	0.00553	0.00837	CcSEcCtD
Molindone—Tremor—Amprenavir—acquired immunodeficiency syndrome	0.00544	0.00823	CcSEcCtD
Molindone—Weight decreased—Zidovudine—acquired immunodeficiency syndrome	0.00518	0.00784	CcSEcCtD
Molindone—Disturbance in sexual arousal—Ritonavir—acquired immunodeficiency syndrome	0.00511	0.00774	CcSEcCtD
Molindone—Disturbance in sexual arousal—Saquinavir—acquired immunodeficiency syndrome	0.00492	0.00745	CcSEcCtD
Molindone—Urinary retention—Ritonavir—acquired immunodeficiency syndrome	0.0049	0.00742	CcSEcCtD
Molindone—Weight increased—Indinavir—acquired immunodeficiency syndrome	0.00485	0.00734	CcSEcCtD
Molindone—Dysphagia—Delavirdine—acquired immunodeficiency syndrome	0.00482	0.00729	CcSEcCtD
Molindone—Leukopenia—Didanosine—acquired immunodeficiency syndrome	0.00474	0.00717	CcSEcCtD
Molindone—HTR7—digestive system—acquired immunodeficiency syndrome	0.00451	0.0205	CbGeAlD
Molindone—Drowsiness—Efavirenz—acquired immunodeficiency syndrome	0.00449	0.00679	CcSEcCtD
Molindone—Dysphagia—Ritonavir—acquired immunodeficiency syndrome	0.00445	0.00674	CcSEcCtD
Molindone—Muscle spasms—Nelfinavir—acquired immunodeficiency syndrome	0.00443	0.0067	CcSEcCtD
Molindone—CHRM1—lung—acquired immunodeficiency syndrome	0.00442	0.0201	CbGeAlD
Molindone—Dry mouth—Didanosine—acquired immunodeficiency syndrome	0.00441	0.00667	CcSEcCtD
Molindone—Weight increased—Delavirdine—acquired immunodeficiency syndrome	0.00438	0.00663	CcSEcCtD
Molindone—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.00433	0.0197	CbGeAlD
Molindone—HTR7—blood—acquired immunodeficiency syndrome	0.0043	0.0196	CbGeAlD
Molindone—Dysphagia—Saquinavir—acquired immunodeficiency syndrome	0.00429	0.00649	CcSEcCtD
Molindone—Agitation—Nelfinavir—acquired immunodeficiency syndrome	0.00423	0.00641	CcSEcCtD
Molindone—HTR7—spinal cord—acquired immunodeficiency syndrome	0.00414	0.0189	CbGeAlD
Molindone—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00412	0.00624	CcSEcCtD
Molindone—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.00411	0.00622	CcSEcCtD
Molindone—CHRM1—nervous system—acquired immunodeficiency syndrome	0.00409	0.0187	CbGeAlD
Molindone—Dysphagia—Lamivudine—acquired immunodeficiency syndrome	0.00409	0.00619	CcSEcCtD
Molindone—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.00405	0.00613	CcSEcCtD
Molindone—Weight decreased—Ritonavir—acquired immunodeficiency syndrome	0.00403	0.0061	CcSEcCtD
Molindone—HTR2A—retina—acquired immunodeficiency syndrome	0.004	0.0182	CbGeAlD
Molindone—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.00394	0.018	CbGeAlD
Molindone—Weight increased—Saquinavir—acquired immunodeficiency syndrome	0.0039	0.0059	CcSEcCtD
Molindone—Weight decreased—Saquinavir—acquired immunodeficiency syndrome	0.00388	0.00587	CcSEcCtD
Molindone—Muscle spasms—Zidovudine—acquired immunodeficiency syndrome	0.00384	0.00581	CcSEcCtD
Molindone—Dry mouth—Stavudine—acquired immunodeficiency syndrome	0.00382	0.00579	CcSEcCtD
Molindone—HTR7—lung—acquired immunodeficiency syndrome	0.00377	0.0172	CbGeAlD
Molindone—Tremor—Zidovudine—acquired immunodeficiency syndrome	0.00374	0.00566	CcSEcCtD
Molindone—HTR1A—nervous system—acquired immunodeficiency syndrome	0.00365	0.0166	CbGeAlD
Molindone—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.00357	0.00541	CcSEcCtD
Molindone—Muscle spasms—Indinavir—acquired immunodeficiency syndrome	0.00357	0.0054	CcSEcCtD
Molindone—DRD2—lung—acquired immunodeficiency syndrome	0.00356	0.0162	CbGeAlD
Molindone—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.00351	0.016	CbGeAlD
Molindone—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.0035	0.00529	CcSEcCtD
Molindone—HTR7—nervous system—acquired immunodeficiency syndrome	0.00349	0.0159	CbGeAlD
Molindone—Tremor—Indinavir—acquired immunodeficiency syndrome	0.00348	0.00526	CcSEcCtD
Molindone—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.00345	0.00522	CcSEcCtD
Molindone—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00345	0.00522	CcSEcCtD
Molindone—Agitation—Indinavir—acquired immunodeficiency syndrome	0.00341	0.00516	CcSEcCtD
Molindone—HTR7—central nervous system—acquired immunodeficiency syndrome	0.00336	0.0153	CbGeAlD
Molindone—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00335	0.00507	CcSEcCtD
Molindone—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00334	0.00506	CcSEcCtD
Molindone—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.00333	0.00504	CcSEcCtD
Molindone—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.00331	0.005	CcSEcCtD
Molindone—DRD2—nervous system—acquired immunodeficiency syndrome	0.0033	0.015	CbGeAlD
Molindone—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00329	0.00498	CcSEcCtD
Molindone—Tremor—Efavirenz—acquired immunodeficiency syndrome	0.00329	0.00497	CcSEcCtD
Molindone—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.00323	0.00488	CcSEcCtD
Molindone—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.00322	0.00488	CcSEcCtD
Molindone—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00321	0.00485	CcSEcCtD
Molindone—DRD2—central nervous system—acquired immunodeficiency syndrome	0.00317	0.0145	CbGeAlD
Molindone—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00316	0.00479	CcSEcCtD
Molindone—ADRA2A—blood—acquired immunodeficiency syndrome	0.00315	0.0144	CbGeAlD
Molindone—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.00314	0.00476	CcSEcCtD
Molindone—CHRM1—brain—acquired immunodeficiency syndrome	0.00313	0.0143	CbGeAlD
Molindone—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.00309	0.00468	CcSEcCtD
Molindone—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.00308	0.00467	CcSEcCtD
Molindone—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.00304	0.0138	CbGeAlD
Molindone—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.003	0.00455	CcSEcCtD
Molindone—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00299	0.00452	CcSEcCtD
Molindone—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.00298	0.00452	CcSEcCtD
Molindone—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00298	0.00451	CcSEcCtD
Molindone—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00293	0.00443	CcSEcCtD
Molindone—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.00292	0.00442	CcSEcCtD
Molindone—ADRA2A—vagina—acquired immunodeficiency syndrome	0.00292	0.0133	CbGeAlD
Molindone—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.00291	0.0044	CcSEcCtD
Molindone—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00291	0.0044	CcSEcCtD
Molindone—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.0029	0.00438	CcSEcCtD
Molindone—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.00287	0.00435	CcSEcCtD
Molindone—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.00285	0.00432	CcSEcCtD
Molindone—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00281	0.00426	CcSEcCtD
Molindone—HTR2A—digestive system—acquired immunodeficiency syndrome	0.00281	0.0128	CbGeAlD
Molindone—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.0028	0.00424	CcSEcCtD
Molindone—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00279	0.00423	CcSEcCtD
Molindone—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00279	0.00423	CcSEcCtD
Molindone—HTR1A—brain—acquired immunodeficiency syndrome	0.00279	0.0127	CbGeAlD
Molindone—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00279	0.00422	CcSEcCtD
Molindone—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00278	0.0042	CcSEcCtD
Molindone—ADRA2A—lung—acquired immunodeficiency syndrome	0.00276	0.0126	CbGeAlD
Molindone—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.00275	0.00415	CcSEcCtD
Molindone—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00274	0.00415	CcSEcCtD
Molindone—Rash—Didanosine—acquired immunodeficiency syndrome	0.00272	0.00412	CcSEcCtD
Molindone—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00272	0.00412	CcSEcCtD
Molindone—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.0027	0.00409	CcSEcCtD
Molindone—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00269	0.00408	CcSEcCtD
Molindone—HTR2A—blood—acquired immunodeficiency syndrome	0.00268	0.0122	CbGeAlD
Molindone—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00267	0.00405	CcSEcCtD
Molindone—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.00267	0.00405	CcSEcCtD
Molindone—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.00267	0.00404	CcSEcCtD
Molindone—HTR7—brain—acquired immunodeficiency syndrome	0.00267	0.0121	CbGeAlD
Molindone—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00259	0.00392	CcSEcCtD
Molindone—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00258	0.00391	CcSEcCtD
Molindone—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.00258	0.0118	CbGeAlD
Molindone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00257	0.00388	CcSEcCtD
Molindone—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00256	0.00387	CcSEcCtD
Molindone—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.00256	0.0117	CbGeAlD
Molindone—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00255	0.00386	CcSEcCtD
Molindone—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00255	0.00386	CcSEcCtD
Molindone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00255	0.00385	CcSEcCtD
Molindone—DRD2—brain—acquired immunodeficiency syndrome	0.00252	0.0115	CbGeAlD
Molindone—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00249	0.00376	CcSEcCtD
Molindone—HTR2A—vagina—acquired immunodeficiency syndrome	0.00248	0.0113	CbGeAlD
Molindone—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00247	0.00374	CcSEcCtD
Molindone—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.00246	0.0112	CbGeAlD
Molindone—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00245	0.0037	CcSEcCtD
Molindone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00245	0.0037	CcSEcCtD
Molindone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00245	0.0037	CcSEcCtD
Molindone—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00244	0.0037	CcSEcCtD
Molindone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00244	0.00368	CcSEcCtD
Molindone—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00237	0.00359	CcSEcCtD
Molindone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00237	0.00359	CcSEcCtD
Molindone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00237	0.00358	CcSEcCtD
Molindone—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00237	0.00358	CcSEcCtD
Molindone—Rash—Stavudine—acquired immunodeficiency syndrome	0.00236	0.00358	CcSEcCtD
Molindone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00236	0.00357	CcSEcCtD
Molindone—HTR2A—lung—acquired immunodeficiency syndrome	0.00235	0.0107	CbGeAlD
Molindone—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00234	0.00354	CcSEcCtD
Molindone—Rash—Abacavir—acquired immunodeficiency syndrome	0.00233	0.00352	CcSEcCtD
Molindone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00233	0.00352	CcSEcCtD
Molindone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00231	0.00349	CcSEcCtD
Molindone—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00228	0.00345	CcSEcCtD
Molindone—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00226	0.00342	CcSEcCtD
Molindone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00225	0.00341	CcSEcCtD
Molindone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00223	0.00338	CcSEcCtD
Molindone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00223	0.00337	CcSEcCtD
Molindone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00219	0.00332	CcSEcCtD
Molindone—HTR2A—nervous system—acquired immunodeficiency syndrome	0.00217	0.00991	CbGeAlD
Molindone—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00217	0.00329	CcSEcCtD
Molindone—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00217	0.00329	CcSEcCtD
Molindone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00217	0.00328	CcSEcCtD
Molindone—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00217	0.00328	CcSEcCtD
Molindone—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.00209	0.00954	CbGeAlD
Molindone—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00209	0.00315	CcSEcCtD
Molindone—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00207	0.00314	CcSEcCtD
Molindone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00207	0.00313	CcSEcCtD
Molindone—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00205	0.00311	CcSEcCtD
Molindone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00205	0.00311	CcSEcCtD
Molindone—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00199	0.00301	CcSEcCtD
Molindone—ADRA2A—brain—acquired immunodeficiency syndrome	0.00195	0.00891	CbGeAlD
Molindone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00194	0.00293	CcSEcCtD
Molindone—Rash—Indinavir—acquired immunodeficiency syndrome	0.00191	0.00289	CcSEcCtD
Molindone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00191	0.00289	CcSEcCtD
Molindone—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.00189	0.00861	CbGeAlD
Molindone—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00181	0.00273	CcSEcCtD
Molindone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.0018	0.00273	CcSEcCtD
Molindone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.0018	0.00272	CcSEcCtD
Molindone—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00173	0.00261	CcSEcCtD
Molindone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00173	0.00261	CcSEcCtD
Molindone—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.0017	0.00257	CcSEcCtD
Molindone—HTR2A—brain—acquired immunodeficiency syndrome	0.00166	0.00757	CbGeAlD
Molindone—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00163	0.00246	CcSEcCtD
Molindone—Rash—Ritonavir—acquired immunodeficiency syndrome	0.0016	0.00242	CcSEcCtD
Molindone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.0016	0.00241	CcSEcCtD
Molindone—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00154	0.00233	CcSEcCtD
Molindone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00154	0.00232	CcSEcCtD
Molindone—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.0015	0.00228	CcSEcCtD
Molindone—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00147	0.00222	CcSEcCtD
Molindone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00147	0.00222	CcSEcCtD
Molindone—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00145	0.00219	CcSEcCtD
Molindone—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00138	0.00209	CcSEcCtD
Molindone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000346	0.0029	CbGpPWpGaD
Molindone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000346	0.0029	CbGpPWpGaD
Molindone—HTR7—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000345	0.00288	CbGpPWpGaD
Molindone—ADRA2A—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.000343	0.00287	CbGpPWpGaD
Molindone—HTR2A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000341	0.00285	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000339	0.00284	CbGpPWpGaD
Molindone—HTR1A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000336	0.00281	CbGpPWpGaD
Molindone—HTR1A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000336	0.00281	CbGpPWpGaD
Molindone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000335	0.0028	CbGpPWpGaD
Molindone—DRD2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000334	0.00279	CbGpPWpGaD
Molindone—ADRA2A—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000331	0.00277	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000328	0.00274	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00032	0.00267	CbGpPWpGaD
Molindone—DRD2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000313	0.00262	CbGpPWpGaD
Molindone—HTR7—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00031	0.00259	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00031	0.00259	CbGpPWpGaD
Molindone—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00031	0.00259	CbGpPWpGaD
Molindone—HTR2A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000308	0.00258	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000307	0.00256	CbGpPWpGaD
Molindone—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000305	0.00255	CbGpPWpGaD
Molindone—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000303	0.00253	CbGpPWpGaD
Molindone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000302	0.00253	CbGpPWpGaD
Molindone—ADRA2A—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000299	0.0025	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000297	0.00248	CbGpPWpGaD
Molindone—DRD2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000295	0.00246	CbGpPWpGaD
Molindone—DRD2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000295	0.00246	CbGpPWpGaD
Molindone—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000294	0.00246	CbGpPWpGaD
Molindone—HTR2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00029	0.00242	CbGpPWpGaD
Molindone—HTR2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00029	0.00242	CbGpPWpGaD
Molindone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00029	0.00242	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000288	0.00241	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000288	0.00241	CbGpPWpGaD
Molindone—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000288	0.00241	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000288	0.00241	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000283	0.00237	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000282	0.00236	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000281	0.00235	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000281	0.00235	CbGpPWpGaD
Molindone—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000277	0.00232	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000276	0.00231	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000275	0.0023	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000273	0.00229	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000272	0.00228	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—TAT—acquired immunodeficiency syndrome	0.000268	0.00224	CbGpPWpGaD
Molindone—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000265	0.00222	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000264	0.00221	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000264	0.00221	CbGpPWpGaD
Molindone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000264	0.0022	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000261	0.00218	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000261	0.00218	CbGpPWpGaD
Molindone—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000261	0.00218	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00026	0.00218	CbGpPWpGaD
Molindone—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00026	0.00217	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000258	0.00215	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000256	0.00214	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000256	0.00214	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000256	0.00214	CbGpPWpGaD
Molindone—HTR1A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000255	0.00213	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000255	0.00213	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000251	0.0021	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000247	0.00207	CbGpPWpGaD
Molindone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000237	0.00198	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000236	0.00198	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000233	0.00195	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000232	0.00194	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000232	0.00194	CbGpPWpGaD
Molindone—HTR1A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00023	0.00192	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000228	0.0019	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—IFNA1—acquired immunodeficiency syndrome	0.000226	0.00189	CbGpPWpGaD
Molindone—DRD2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000224	0.00187	CbGpPWpGaD
Molindone—ADRA2A—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	0.000223	0.00187	CbGpPWpGaD
Molindone—HTR1A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000222	0.00185	CbGpPWpGaD
Molindone—HTR2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000221	0.00184	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000219	0.00183	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000203	0.00169	CbGpPWpGaD
Molindone—DRD2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000202	0.00169	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000202	0.00169	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000201	0.00168	CbGpPWpGaD
Molindone—HTR2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000199	0.00166	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000198	0.00165	CbGpPWpGaD
Molindone—HTR7—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000197	0.00165	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000195	0.00163	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000194	0.00162	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000194	0.00162	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000192	0.0016	CbGpPWpGaD
Molindone—HTR2A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	0.000192	0.0016	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00019	0.00159	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00019	0.00159	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000183	0.00153	CbGpPWpGaD
Molindone—ADRA2A—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	0.000181	0.00151	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000181	0.00151	CbGpPWpGaD
Molindone—HTR1A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000179	0.0015	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000178	0.00149	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000177	0.00148	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000177	0.00148	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—CSF2—acquired immunodeficiency syndrome	0.000177	0.00148	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000175	0.00147	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000175	0.00146	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000175	0.00146	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000174	0.00146	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000174	0.00146	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000174	0.00146	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000173	0.00145	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000172	0.00144	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000172	0.00144	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00017	0.00142	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00017	0.00142	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000167	0.0014	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000167	0.0014	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000167	0.00139	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000167	0.00139	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000166	0.00139	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000166	0.00139	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000164	0.00137	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000164	0.00137	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000163	0.00136	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000163	0.00136	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000161	0.00135	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000161	0.00134	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000159	0.00133	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000159	0.00133	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000159	0.00133	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000158	0.00132	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000157	0.00132	CbGpPWpGaD
Molindone—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	0.000155	0.00129	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000154	0.00129	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000152	0.00127	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000152	0.00127	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000151	0.00127	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000151	0.00126	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000151	0.00126	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000151	0.00126	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000149	0.00125	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000149	0.00125	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000149	0.00124	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000149	0.00124	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000148	0.00124	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000148	0.00124	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000146	0.00122	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000144	0.00121	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000144	0.0012	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000142	0.00119	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000138	0.00115	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000137	0.00115	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000137	0.00115	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000135	0.00113	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000135	0.00113	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000131	0.0011	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00013	0.00109	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000129	0.00108	CbGpPWpGaD
Molindone—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000128	0.00107	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000127	0.00106	CbGpPWpGaD
Molindone—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	0.000126	0.00105	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000125	0.00104	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000125	0.00104	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000124	0.00104	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000123	0.00103	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000122	0.00102	CbGpPWpGaD
Molindone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00012	0.001	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00012	0.001	CbGpPWpGaD
Molindone—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000119	0.000995	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000118	0.000987	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	0.000115	0.000963	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000115	0.000962	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000114	0.000954	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000113	0.000948	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000113	0.000947	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000113	0.000946	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000113	0.000941	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000112	0.000939	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000112	0.000934	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000112	0.000934	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000112	0.000932	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000111	0.000927	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000108	0.000905	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000105	0.000878	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000104	0.000873	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000104	0.000866	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000103	0.000864	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000103	0.000861	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000103	0.00086	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000103	0.00086	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000102	0.000854	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000102	0.000853	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000102	0.000851	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000102	0.000851	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000101	0.000848	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000101	0.000848	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000101	0.000847	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.5e-05	0.000794	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.41e-05	0.000787	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	9.41e-05	0.000786	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.35e-05	0.000782	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	9.34e-05	0.000781	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	9.3e-05	0.000777	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	9.28e-05	0.000776	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.2e-05	0.000769	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.93e-05	0.000747	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.93e-05	0.000747	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.79e-05	0.000735	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.79e-05	0.000735	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8.74e-05	0.000731	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8.74e-05	0.000731	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	8.51e-05	0.000711	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	8e-05	0.000668	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	8e-05	0.000668	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.74e-05	0.000647	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.63e-05	0.000637	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.51e-05	0.000628	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.97e-05	0.000583	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.82e-05	0.00057	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.8e-05	0.000568	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.69e-05	0.00056	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.69e-05	0.000559	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.65e-05	0.000556	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.59e-05	0.000551	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.59e-05	0.000551	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	6.55e-05	0.000548	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.49e-05	0.000542	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	6.45e-05	0.00054	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.12e-05	0.000512	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	6.08e-05	0.000509	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.02e-05	0.000504	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	5.99e-05	0.000501	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.99e-05	0.000501	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.99e-05	0.000501	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	5.9e-05	0.000493	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.89e-05	0.000493	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.86e-05	0.00049	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	5.48e-05	0.000458	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.44e-05	0.000455	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.41e-05	0.000452	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	5.36e-05	0.000448	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	4.67e-05	0.00039	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.03e-05	0.000337	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.01e-05	0.000335	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.54e-05	0.000296	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.52e-05	0.000294	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.48e-05	0.000291	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.46e-05	0.00029	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.46e-05	0.000289	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.45e-05	0.000288	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.2e-05	0.000267	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.17e-05	0.000265	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.15e-05	0.000263	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.37e-05	0.000198	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.08e-05	0.000174	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.05e-05	0.000171	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.04e-05	0.00017	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.86e-05	0.000156	CbGpPWpGaD
